Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Authors
Keywords
-
Journal
LANCET
Volume 399, Issue 10329, Pages 1049-1058
Publisher
Elsevier BV
Online
2022-03-11
DOI
10.1016/s0140-6736(22)00012-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series
- (2020) Siddharth Singh et al. BASIC RESEARCH IN CARDIOLOGY
- Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial
- (2020) Raj R Makkar et al. EUROPEAN HEART JOURNAL
- Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial
- (2019) Michael Taylor et al. NEUROLOGY
- Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology
- (2019) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Performance of Upper Limb module for Duchenne muscular dystrophy
- (2019) Anna G Mayhew et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors
- (2019) Anita Kruzik et al. Molecular Therapy-Methods & Clinical Development
- Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients
- (2018) Christian Leborgne et al. CELLULAR IMMUNOLOGY
- Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study
- (2018) Craig M McDonald et al. LANCET
- Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data
- (2018) Marika Pane et al. PLoS One
- Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy
- (2018) Mark A. Aminzadeh et al. Stem Cell Reports
- A mechanistic roadmap for the clinical application of cardiac cell therapies
- (2018) Eduardo Marbán Nature Biomedical Engineering
- Longitudinal Pulmonary Function Testing Outcome Measures in Duchenne Muscular Dystrophy: Long-term Natural History with and without Glucocorticoids
- (2018) Craig M. McDonald et al. NEUROMUSCULAR DISORDERS
- Cardiac Management of the Patient With Duchenne Muscular Dystrophy
- (2018) Sujatha Buddhe et al. PEDIATRICS
- The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
- (2017) S. Ryder et al. Orphanet Journal of Rare Diseases
- Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM
- (2016) K Klingels et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction
- (2015) Geoffrey de Couto et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles
- (2015) Eleni Tseliou et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Immune-mediated pathology in Duchenne muscular dystrophy
- (2015) Amy S. Rosenberg et al. Science Translational Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started